Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain

Virology Journal

Volumn 9, Issue , 2012, Pages

  Arroyo, Sara L ^a   Basaras, Miren ^a   Arrese, Elixabete ^a   Hernáez, Silvia ^b   Andía, Daniel ^b   Esteban, Valentín ^b   Garcia Etxebarria, Koldo ^a   Jugo, Begoña M ^a   Cisterna, Ramón ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

Author keywords

Genotype 18; Human papillomavirus infection; Multiple infection; Recombination; Variants

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASIAN; EUROPEAN AMERICAN; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SPAIN;

DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMAN PAPILLOMAVIRUS 18; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SPAIN; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS;

EID: 84868240115     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-258     Document Type: Article

References (27)

1. HPV in the etiology of human cancer. Muñoz N, Castellsague X, de Gonzalez AB, Gissmann L, Vaccine 2006 24 1 10 10.1016/j.vaccine.2005.07.047 16122853 (Pubitemid 41721095)
2. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Int J Cancer 2007 121 621 632 10.1002/ijc.22527 17405118 (Pubitemid 46986496)
3. Against which human papillomavirus types shall we vaccinate and screen? the international perspective. Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al. Int J Cancer 2004 111 278 285 10.1002/ijc.20244 15197783 (Pubitemid 38924707)
4. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al. J Virol 1997 71 2463 2472 9032384 (Pubitemid 27078630)
5. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. Ong CK, Chan SY, Campo MS, Campo MS, Fujinaga K, Mavromara-Nazos P, et al. J Virol 1993 67 6424 6431 8411344 (Pubitemid 23309106)
6. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. de Araujo Souza PS, Sichero L, Macia PC, Future Oncol 2009 5 359 370 10.2217/fon.09.8 19374542
7. High grade cervical lesions are caused preferentially by non-european variants of HPVs 16 and 18. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, et al. Int J Cancer 2007 120 1763 1768 10.1002/ijc.22481 17230525 (Pubitemid 46399363)
8. Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. López-Savedra A, González-Maya L, de Ponce León S, García-Carranca A, Mohar A, Lizano M, Arch Virol 2009 154 747 754 10.1007/s00705-009-0362-4 19337781
9. Classification of papillomaviruses. de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur HH, Virology 2004 324 17 27 10.1016/j.virol.2004.03.033 15183049 (Pubitemid 38737395)
10. Evidence of recombination within human alpha-papillomavirus. Angulo M, Carvajal-Rodríguez A, Virol J 2007 4 33 10.1186/1743-422X-4-33 17391520 (Pubitemid 46550034)
11. Identification of recombinant human papillomavirus type 16 variants. Jiang M, Xi LF, Edelstein ZR, Galloway DA, Olsem GJ, Lin WC, et al. Virology 2009 394 8 11 10.1016/j.virol.2009.08.040 19758676
12. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. Méndez F, Muñoz N, Posso H, Molano M, Moreno V, van den Brule AJ, et al. J Infect Dis 2005 192 1158 1165 10.1086/444391 16136457 (Pubitemid 41368414)
13. Molecular methods for a correct diagnosis of multiple HPV infections and clinical implications for vaccine. Tinelli A, Leo G, DellEdera D, Storelli F, Galante MM, Guido M, et al. Int J Gynecol Cancer 2011 21 545 550 10.1097/IGC.0b013e31820f5eed 21430458
14. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, et al. Cancer Epidemiol Biomarkers Prev 2009 18 1077 1083 10.1158/1055-9965.EPI-08-0447 19318438
15. RDP3: a flexible and fast computer program for analyzing recombination. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P, Bioinformatics 2010 26 2462 2463 10.1093/bioinformatics/btq467 20798170
16. Analyzing the mosaic structure of genes. Smith J, J Mol Evol 1992 34 126 129 1556748
17. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, et al. J Natl Cancer Inst 2006 98 1045 1052 10.1093/jnci/djj297 16882941 (Pubitemid 44288152)
18. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Im SS, Wilczynski SP, Burge RA, Monk BJ, Clin Cancer Res 2003 9 4145 4150 14519638 (Pubitemid 37204032)
19. Human papillomavirus type 18: association with poor prognosis in early stage cancer. Burger R, Monk BJ, Kurosaki T, Anton-Culver H, Vasiley SA, Berman ML, et al. J Natl Cancer Inst 1996 88 1361 1368 10.1093/jnci/88.19.1361 8827013 (Pubitemid 26329753)
20. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Hecht J, Kadish A, Jiang G, Burk R, Int J Cancer 1995 60 369 376 10.1002/ijc.2910600317 7829247
21. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasma. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, et al. J Gen Virol 2000 81 2959 2968 11086127 (Pubitemid 32000643)
22. Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. Rose B, Steger G, Dong XP, Thompson C, Cossart Y, Tattersall M, et al. J Gen Virol 1998 79 1659 1663 9680128 (Pubitemid 28330669)
23. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Rose B, Thompson CH, Zhang J, Stoeter M, Stephen A, Pfister H, et al. Gynecol Oncol 1997 66 282 289 10.1006/gyno.1997.4740 9264577 (Pubitemid 27335418)
24. Sequencing errors in reference HPV clones. Meissner J, et al. Human papillomaviruses. A compilation and analysis of nucleic acid and amino acid sequences Los Alamos (NM): Theoretical Biology and Biophysics, Los Alamos National Laboratory, Myers G, Baker C, Munger K, 3 1997 110 123
25. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Arias-Pulido H, Peyton CL, Torrez-Martinez N, Anderson DN, Wheeler CM, Virology 2005 338 22 34 10.1016/j.virol.2005.04.022 15936050 (Pubitemid 40835923)
26. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45 and 97. Chen Z, DeSalle R, Schiffmn M, Herrero R, Burk RD, J Virol 2009 83 1443 1455 10.1128/JVI.02068-08 19036820
27. MrBayes 3: Bayesian phylogenetic inference under mixed models. Ronquist F, Huelsenbeck JP, Bioinformatics 2003 19 1572 1574 10.1093/bioinformatics/ btg180 12912839 (Pubitemid 37038874)